25CN-NBOMe

25CN-NBOMe
Identifiers
	IUPAC name 2,5-Dimethoxy-4-(2-(2-methoxybenzylamino)ethyl)benzonitrile;
CAS Number	1354632-16-8;
Chemical and physical data
Formula	C19H22N2O3
Molar mass	326.39 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES N#CC1=CC(OC)=C(CCNCC2=C(OC)C=CC=C2)C=C1OC;

25CN-NBOMe (2C-CN-NBOMe, NBOMe-2C-CN) is a derivative of the phenethylamine 2C-CN. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5HT_2A receptor.^[1]^[2] 25CN-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

References

^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/cn400216u, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1021/cn400216u instead.
^ Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

[1] Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/cn400216u, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1021/cn400216u instead.

[2] Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.

[1]

[2]

See also

References